Clinical Report: Immune Landscape Alterations After Curative R0 Resection of Colorectal Liver Metastases

Overview

This study investigates the immune landscape changes following curative R0 resection in colorectal cancer liver metastases (CRLM) patients. Key findings include a significant increase in circulating CD4+ T cells and alterations in exhaustion markers.

Background

Colorectal cancer liver metastases are a major contributor to systemic immunosuppression and poor prognosis. Understanding the immune landscape post-resection is crucial for characterizing immune reprogramming.

Data Highlights

No numerical data available in the source material.

Key Findings

• Postoperative analysis showed an increased proportion of CD4+ T cells among circulating CD3+ T cells.
• The percentage of TIM3+ CD4+ T cells decreased significantly post-resection.
• Regulatory T cells and T follicular helper cells remained unchanged after surgery.
• Patients with recurrence had a higher postoperative proportion of S100A9+ monocytic myeloid-derived suppressor cells.
• KRAS-mutated tumors may be associated with distinct postoperative immune profiles.

Clinical Implications

Further investigation is warranted to explore the relevance of these changes in the context of adoptive cellular therapies and immune checkpoint inhibition.

Conclusion

The study highlights significant immune remodeling following liver resection in CRLM patients. Further research is needed to validate these findings.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. The ASCO Post — Colorectal Cancer Liver Metastases: Transplant or Resect?
5. The ASCO Post — Colorectal Cancer Liver Metastases: Transplant or Resect?
6. Colorectal Cancer Liver Metastases: Transplant or Resect?
7. NAFLD-associated immune remodeling in colorectal cancer liver metastasis
8. ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
9. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial - PMC
10. Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment | Clinical Cancer Research | American Association for Cancer Research